Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy
The incidence of FN in the peg-filgrastim arm was significantly lesser. No significant adverse events attributable to the study drug were reported.
Authors
- Anita Chopra (ORCID: https://orcid.org/0000-0002-0238-8702)
- Jagdish Prasad Meena (ORCID: https://orcid.org/0000-0001-6024-9762)
- Meena Haldorai
- Rachna Seth
- R. M. Pandey (ORCID: https://orcid.org/0000-0003-2147-3109)
- Aditya Kumar Gupta
Institutions
- Pediatric Oncology Group (CA)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1097/coc.0000000000001199
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00